We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$1.51B
AUM Growth
-$77.3M
Cap. Flow
+$91M
Cap. Flow %
6.03%
Top 10 Hldgs %
47.01%
Holding
89
New
28
Increased
20
Reduced
17
Closed
23

Top Buys

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$43.2M
2
BIIB icon
Biogen
BIIB
+$27.9M
3
ORLY icon
O'Reilly Automotive
ORLY
+$26.2M
4
VFC icon
VF Corp
VFC
+$24.3M
5
CMG icon
Chipotle Mexican Grill
CMG
+$23.9M

Top Sells

Rank Stock Value
1
DFRG
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
+$48.8M
2
EPC icon
Edgewell Personal Care
EPC
+$46M
3
BURL icon
Burlington
BURL
+$38.1M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$28.1M
5
RH icon
RH
RH
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 42.07%
2 Miscellaneous 28.56%
3 Consumer Discretionary 17.83%
4 Consumer Staples 5.02%
5 Industrials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RL icon
26
Ralph Lauren
RL
$20.8B
$22.1M 1.47%
+232,000
New +$22.9M
DBX icon
27
Dropbox
DBX
$7.34B
$20.2M 1.34%
1,000,000
+50,000
+5% +$1.07M
WEN icon
28
Wendy's
WEN
$1.45B
$20M 1.32%
+1,000,000
New +$19.9M
UNH icon
29
UnitedHealth
UNH
$361B
$19.1M 1.27%
+88,000
New +$21.2M
FTDR icon
30
Frontdoor
FTDR
$5.63B
$19M 1.26%
392,000
-108,000
-22% -$5.21M
VYGR icon
31
Voyager Therapeutics
VYGR
$213M
$18.9M 1.25%
1,096,000
+160,000
+17% +$3.36M
ATRS
32
DELISTED
Antares Pharma, Inc.
ATRS
$18.8M 1.25%
5,624,000
-376,000
-6% -$1.24M
UTHR icon
33
United Therapeutics
UTHR
$21.5B
$18.3M 1.22%
230,000
-94,000
-29% -$7.57M
BOLD
34
DELISTED
Audentes Therapeutics, Inc
BOLD
$17.9M 1.18%
+636,000
New +$21.7M
WING icon
35
Wingstop
WING
$2.97B
$12.9M 0.86%
+148,000
New +$14.1M
QSR icon
36
Restaurant Brands International
QSR
$27.4B
$12.8M 0.85%
180,000
-3,000
-2% -$221K
LOW icon
37
Lowe's Companies
LOW
$113B
$12.8M 0.85%
116,000
-227,000
-66% -$24M
ULTA icon
38
Ulta Beauty
ULTA
$23.6B
$11.7M 0.77%
+46,500
New +$14.3M
MRK icon
39
Merck
MRK
$368B
$11.4M 0.76%
+142,528
New +$11.4M
CRSP icon
40
CRISPR Therapeutics
CRSP
$5.29B
$10.8M 0.72%
+264,000
New +$12.6M
TSCO icon
41
Tractor Supply
TSCO
$18.3B
$9.77M 0.65%
+540,000
New +$11.2M
MNK
42
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$9.64M 0.64%
40,000
-3,560,000
-99% -$18.2M
MDGL icon
43
Madrigal Pharmaceuticals
MDGL
$12.3B
$9.31M 0.62%
108,000
-300,000
-74% -$28.1M
VXRT
44
DELISTED
Vaxart
VXRT
$8.62M 0.57%
+24,000,000
New +$15.7M
KPRX icon
45
Kiora Pharmaceuticals
KPRX
$11.1M
$8.44M 0.56%
4,979
+1,680
+51% +$1.93M
TWNK
46
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$8.11M 0.54%
+580,000
New +$8.22M
BBWI icon
47
Bath & Body Works
BBWI
$3.78B
$8.03M 0.53%
+507,170
New +$8.95M
CLVS
48
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$7.86M 0.52%
20,000
-2,195,600
-99% -$17.8M
PRTK
49
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6.79M 0.45%
1,572,000
-906,000
-37% -$3.62M
AYTU icon
50
AYTU BioPharma
AYTU
$23.7M
$6.2M 0.41%
25,600
+15,600
+156% +$4.7M
1
2
3 4

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Armistice Capital held 89 positions worth $1.51B, down 4.9% from $1.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Armistice Capital deployed $91M of net new capital in Q3 2019, opening 28 new positions and adding to 20 existing holdings. Its largest new stake was Kraft Heinz: 1,500,000 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 37% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $28.1M trimmed.

  • Armistice Capital's largest Q3 2019 buy was Kraft Heinz: 1,500,000 shares worth $41.9M.
  • Armistice Capital added most to Biogen in Q3 2019, an estimated $27.9M increase.
  • Armistice Capital's biggest Q3 2019 reduction was Madrigal Pharmaceuticals, cutting an estimated $28.1M.
  • Armistice Capital fully exited Del Frisco's Restaurant Group, Inc. Common Stock in Q3 2019, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 47% of its $1.51B portfolio in Q3 2019.
  • Armistice Capital opened 28 new positions and closed 23 in Q3 2019.
  • Armistice Capital's portfolio value fell 4.9% quarter-over-quarter to $1.51B.

Based on Armistice Capital's 13F filing for Q3 2019, filed 14 Nov 2019.